ObjectiveTo investigate the distribution characteristics and correlation of paired oral and esophageal microbiota in patients with esophageal squamous cell carcinoma （ESCC）. MethodsA total of 46 pathologically confirmed ESCC patients were enrolled， and oral swabs and cancerous tissue samples were collected. The microbial composition was analyzed using 16S rRNA gene sequencing， and bioinformatics methods were employed to compare the microbiota diversity， compositional differences， and correlations between the two sites. ResultsThe Alpha diversity of the oral microbiota in ESCC patients was significantly higher than that of their esophageal microbiota， though the overall community structure was similar between the two sites. LEfSe analysis revealed that Spirochaetes， Prevotella， Catonella， Enterococcus， Fusobacterium periodonticum， Veillonella parvula， Capnocytophaga sputigena， and Neisseria subflava were significantly enriched in ESCC tumor tissues. In contrast， Actinobacteria， Proteobacteria， Streptococcus， Neisseria， Haemophilus， Streptococcus mitis， Haemophilus parainfluenzae， Porphyromonas gingivalis， Haemophilus haemolyticus， and Prevotella tannerae were significantly enriched in the oral cavity. Correlation analysis demonstrated significant associations between the two sites at taxonomic levels such as Spirochaetes， Treponema， Granulicatella elegans， Neisseria macacae， Treponema amylovorum， Fusobacterium periodonticum， and Neisseria meningitidis （P<0.05）. ConclusionThe oral and esophageal microbiota in ESCC patients exhibit both distinct differences and similarities. Oral microbiota may influence the esophageal microenvironment through migration or local immune modulation.

Objective·To determine hyaluronan(HA)expression in the endocrine-resistant microenvironment of estrogen receptor-positive(ER+)breast cancer and elucidate its impact on the acquired resistance.Methods·Chemiluminescent immunoassay was used to quantify HA levels in the culture supernatants of fulvestrant-resistant breast cancer cells.An immunofluorescence(IF)assay was performed to visualize the colocalization of CD44 and HA in MCF7/FulR cells.Using an established adaptive endocrine-resistant breast cancer mouse model,HA expression in resistant breast cancer tissues was assessed by immunohistochemistry(IHC)assay.Single-cell RNA sequencing(scRNA-seq)and RNA sequencing(RNA-seq)were conducted to examine transcriptomic profiles and alterations in HA-related genes in resistant breast cancer cells.Flow cytometry(FCM)was utilized to measure the proportion of CD44+CD24-cells in MCF7/FulR.The correlation between HA synthesis genes and cell stemness was investigated in clinical ER+breast cancers from GEO data sets.Hyaluronidase(HAase)treatment was applied to remove the"HA coat",and RT-qPCR and Western blotting analysis were carried out to monitor changes in stemness-related molecules.CCK-8 assays,flow cytometry(FCM),and Hoechst 33258 staining were performed to determine changes in apoptosis and fulvestrant efficiency after HAase treatment.Results·IF results revealed that compared with MCF7 cells,the"HA coat"on the surface of MCF7/FulR cells was significantly thickened.IHC demonstrated markedly increased HA retention in fulvestrant-resistant mouse breast cancer tissues.ScRNA-seq and RNA-seq analyses indicated elevated expression of stemness-related genes and HA synthesis-associated genes in fulvestrant-resistant breast cancer cells.Correlation analysis revealed a positive association between HA synthesis and cancer stemness in ER+breast cancer.IF and RT-qPCR results demonstrated that removing the HA coating from the surface of MCF7/FulR cells led to a significant reduction in the expression of stemness-related molecules;concurrently,CCK-8 assays,FCM analysis,and Hoechst 33258 staining revealed that"HA coat"clearance reduced MCF7/FulR'tolerance to fulvestrant and increased apoptosis.Conclusion·Endocrine-resistant breast cancer cells develop an enriched"HA coat",which promotes stemness in fulvestrant-resistant tumors.Disruption of this HA coat through HAase treatment effectively reduces cell stemness,induces apoptosis,and re-sensitizes breast cancer cells to fulvestrant.

Objective To explore the clinical application effect of a novel fixation device used for percutaneous transhepatic cholangial drainage(PTCD)tube in patients after receiving PTCD.Methods A novel type of fixed device for PTCD tube was independently designed and produced by authors.One hundred patients,who underwent PTCD(retention time of the tube at least one month)at the Department of Interventional Radiology,Ruijin Hospital,Shanghai Jiao Jong University School of Medicint from September 2024 to April 2025,were collected for this study.According to the order of hospitalization dates,the patients were divided into an observation group(n=50)and a control group(n=50).The patients in the observation group used a novel PTCD tube fixation device as secondary fixation,while the patients in the control group used conventional medical silk tape for cross type secondary fixation.The postoperative 2-hour pain scores,readiness for hospital discharge,comfort level of fixed device during PTCD tube retention for one month,drainage tube dropping-off rate,drainage obstruction rate,and incidence of peripheral dermatitis were compared between the two groups.Results The postoperative 2-hour pain scores and the comfort level after one-month retention of PTCD tube in the observation group were obviously lower than those in the control group,the differences were statistically significant(both P＜0.05).The PTCD tube dropping-off rate,poor drainage rate,and incidence of dermatitis in the observation group during tube retention period were lower than those in the control group(all P＜0.05).The readiness for hospital discharge of both groups was at a medium-to-low level,although the score of the observation group was higher than that of the control group,the difference was not statistically significant(P＞0.05).Conclusion The use of this novel PTCD tube fixation device can effectively increase the comfort level of patients during the period of carrying a tube.The modular ice pack component can alleviate postoperative pain,reduce the incidences of drainage tube dropping-off,drainage obstruction and peripheral dermatitis during tube retention period.Therefore,this novel PTCD drainage tube fixation device is worthy of clinical promotion and use.

Objective: To analyze the occupational health literacy (OHL) level and its influencing factors among key populations in the tertiary industry in Lu'an City, Anhui Province, so as to provide a basis for developing targeted health interventions and improving regional occupational health policies. Methods: A stratified cluster random sampling method was employed to select five categories of key populations from the tertiary industry in Lu'an City as study subjects from August to September 2024. Data on gender, age, education level, and OHL were collected through the National OHL Monitoring Questionnaire for Key Populations. The OHL levels were analyzed, and influencing factors of OHL levels among key populations were analyzed using a multivariable logistic regression model. Results: A total of 1 243 individuals were surveyed, comprising 700 (56.32%) males and 543 (43.68%) females. The median age was 42.00 (interquartile range, 17.00) years. There were 609 individuals with OHL, and the OHL level was 48.99%. The OHL levels in fundamental knowledge of occupational health protection, healthy work styles and behaviors, knowledge of occupational health laws, and basic skills for occupational health protection were 84.71%, 60.34%, 43.93%, and 37.09%, respectively. Multivariable logistic regression analysis showed that educational level (primary school and below, OR=0.149, 95%CI: 0.064-0.344; junior high school, OR=0.340, 95%CI: 0.184-0.629; high school, OR=0.408, 95%CI: 0.230-0.723), average monthly personal income (3 000-<5 000 yuan, OR=1.655, 95%CI: 1.092-2.508; 5 000-<7 000 yuan, OR=2.195, 95%CI: 1.302-3.699; ≥7 000 yuan, OR=2.062, 95%CI: 1.016-4.183), employer nature (private enterprises, OR=2.992, 95%CI: 1.569-5.443), and industry category (education, OR=3.423, 95%CI: 1.407-8.327; courier / food delivery services, OR=0.459, 95%CI: 0.268-0.787; healthcare, OR=7.539, 95%CI: 3.255-17.461) were statistically associated with the OHL level among key population. Conclusion The OHL level among key population in the tertiary industry of Lu'an City can be further enhanced, with educational level, average monthly personal income, employer nature, and industry category identified as the primary influencing factors.

Abstract Esophageal cancer is one of the most common malignant tumors of the digestive system in China , with e-sophageal squamous cell carcinoma (ESCC) being the predominant pathological type. The exact etiology of ESCC remains incompletely understood. With advances in 16S rRNA gene sequencing and metagenomics , microbial dys- biosis has been suggested to play a significant role in the pathogenesis of ESCC. Currently , research on the rela- tionship between microorganisms and ESCC is still in its early stages. This review summarizes the association be- tween oral and esophageal microbiota and ESCC , factors influencing microbial composition , and microbial commu- nities linked to ESCC prognosis , which may contribute to early detection and optimized treatment strategies for ES- CC.

Image 1.

Objective·To determine hyaluronan(HA)expression in the endocrine-resistant microenvironment of estrogen receptor-positive(ER+)breast cancer and elucidate its impact on the acquired resistance.Methods·Chemiluminescent immunoassay was used to quantify HA levels in the culture supernatants of fulvestrant-resistant breast cancer cells.An immunofluorescence(IF)assay was performed to visualize the colocalization of CD44 and HA in MCF7/FulR cells.Using an established adaptive endocrine-resistant breast cancer mouse model,HA expression in resistant breast cancer tissues was assessed by immunohistochemistry(IHC)assay.Single-cell RNA sequencing(scRNA-seq)and RNA sequencing(RNA-seq)were conducted to examine transcriptomic profiles and alterations in HA-related genes in resistant breast cancer cells.Flow cytometry(FCM)was utilized to measure the proportion of CD44+CD24-cells in MCF7/FulR.The correlation between HA synthesis genes and cell stemness was investigated in clinical ER+breast cancers from GEO data sets.Hyaluronidase(HAase)treatment was applied to remove the"HA coat",and RT-qPCR and Western blotting analysis were carried out to monitor changes in stemness-related molecules.CCK-8 assays,flow cytometry(FCM),and Hoechst 33258 staining were performed to determine changes in apoptosis and fulvestrant efficiency after HAase treatment.Results·IF results revealed that compared with MCF7 cells,the"HA coat"on the surface of MCF7/FulR cells was significantly thickened.IHC demonstrated markedly increased HA retention in fulvestrant-resistant mouse breast cancer tissues.ScRNA-seq and RNA-seq analyses indicated elevated expression of stemness-related genes and HA synthesis-associated genes in fulvestrant-resistant breast cancer cells.Correlation analysis revealed a positive association between HA synthesis and cancer stemness in ER+breast cancer.IF and RT-qPCR results demonstrated that removing the HA coating from the surface of MCF7/FulR cells led to a significant reduction in the expression of stemness-related molecules;concurrently,CCK-8 assays,FCM analysis,and Hoechst 33258 staining revealed that"HA coat"clearance reduced MCF7/FulR'tolerance to fulvestrant and increased apoptosis.Conclusion·Endocrine-resistant breast cancer cells develop an enriched"HA coat",which promotes stemness in fulvestrant-resistant tumors.Disruption of this HA coat through HAase treatment effectively reduces cell stemness,induces apoptosis,and re-sensitizes breast cancer cells to fulvestrant.

[Objective]To analyze the thought of Professor HE Ruoping in applying Xiaoyao Powder,in order to expand the clinical application of Xiaoyao Powder,and improve the ability of clinical syndrome differentiation and prescription selection.[Methods]Through daily consultations with teachers,collecting medical cases and literature retrieval,this paper discusses the new interpretation of the modification of Xiaoyao Powder.It also presents typical medical cases treated with this formula for conditions such as menstrual disorders,anxiety disorders,ovarian cysts and human papillomavirus(HPV)infection.Furthermore,it summarizes Professor HE's clinical experience in applying Xiaoyao Powder.[Results]Professor HE suggests modifying the original Xiaoyao Powder by removing Mentha haplocalyx Briq.,replacing Zingiber officinale Rosc.with Zingiber officinale Rosc.(dried)to enhance the formula's ability to warm the middle and disperse cold.Additionally,she adds Paeonia suffruticosa Andr.to invigorate blood and dispel blood stasis,thus strengthening the formula's overall effect of promoting blood circulation and tonifying the spleen.Cases treated with Xiaoyao Powder as the base formula such as menstrual disorders,anxiety,ovarian cysts and HPV infections shared the common pathogenesis of liver Qi stagnation and spleen deficiency.By combining differentiation of syndromes with appropriate treatment methods,including regulating and harmonizing Qi and blood,clearing and draining heat and blood stasis,resolving masses and transforming blood stasis,and clearing heat and draining dampness,good therapeutic results were achieved.[Conclusion]Professor HE's clinical application of Xiaoyao Powder often removes Mentha haplocalyx Briq.,and uses Zingiber officinale Rosc.(dried)instead of Zingiber officinale Rosc.added with Paeonia suffruticosa Andr.She believes that this formula can be used for gynecological,psychiatric and other diseases that belong to liver depression and spleen deficiency.Different diseases can be treated with the same formula,expanding the scope of treatment and fully reflecting the role of syndrome differentiation and treatment.It is worth promoting and learning from.

Debates persist regarding the efficacy and safety of azvudine, particularly its real-world outcomes. This study involved patients aged ≥60 years who were admitted to 25 hospitals in mainland China with confirmed SARS-CoV-2 infection between December 1, 2022, and February 28, 2023. Efficacy outcomes were all-cause mortality during hospitalization, the proportion of patients discharged with recovery, time to nucleic acid-negative conversion (T _NANC), time to symptom improvement (T _SI), and time of hospital stay (T _HS). Safety was also assessed. Among the 5884 participants identified, 1999 received azvudine, and 1999 matched controls were included after exclusion and propensity score matching. Azvudine recipients exhibited lower all-cause mortality compared with controls in the overall population (13.3% vs. 17.1%, RR, 0.78; 95% CI, 0.67-0.90; P = 0.001) and in the severe subgroup (25.7% vs. 33.7%; RR, 0.76; 95% CI, 0.66-0.88; P < 0.001). A higher proportion of patients discharged with recovery, and a shorter T _NANC were associated with azvudine recipients, especially in the severe subgroup. The incidence of adverse events in azvudine recipients was comparable to that in the control group (2.3% vs. 1.7%, P = 0.170). In conclusion, azvudine showed efficacy and safety in older patients hospitalized with COVID-19 during the SARS-CoV-2 omicron wave in China.

[Objective]To analyze the thought of Professor HE Ruoping in applying Xiaoyao Powder,in order to expand the clinical application of Xiaoyao Powder,and improve the ability of clinical syndrome differentiation and prescription selection.[Methods]Through daily consultations with teachers,collecting medical cases and literature retrieval,this paper discusses the new interpretation of the modification of Xiaoyao Powder.It also presents typical medical cases treated with this formula for conditions such as menstrual disorders,anxiety disorders,ovarian cysts and human papillomavirus(HPV)infection.Furthermore,it summarizes Professor HE's clinical experience in applying Xiaoyao Powder.[Results]Professor HE suggests modifying the original Xiaoyao Powder by removing Mentha haplocalyx Briq.,replacing Zingiber officinale Rosc.with Zingiber officinale Rosc.(dried)to enhance the formula's ability to warm the middle and disperse cold.Additionally,she adds Paeonia suffruticosa Andr.to invigorate blood and dispel blood stasis,thus strengthening the formula's overall effect of promoting blood circulation and tonifying the spleen.Cases treated with Xiaoyao Powder as the base formula such as menstrual disorders,anxiety,ovarian cysts and HPV infections shared the common pathogenesis of liver Qi stagnation and spleen deficiency.By combining differentiation of syndromes with appropriate treatment methods,including regulating and harmonizing Qi and blood,clearing and draining heat and blood stasis,resolving masses and transforming blood stasis,and clearing heat and draining dampness,good therapeutic results were achieved.[Conclusion]Professor HE's clinical application of Xiaoyao Powder often removes Mentha haplocalyx Briq.,and uses Zingiber officinale Rosc.(dried)instead of Zingiber officinale Rosc.added with Paeonia suffruticosa Andr.She believes that this formula can be used for gynecological,psychiatric and other diseases that belong to liver depression and spleen deficiency.Different diseases can be treated with the same formula,expanding the scope of treatment and fully reflecting the role of syndrome differentiation and treatment.It is worth promoting and learning from.